HEXO Corp (HEXO)
0.71
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
HEXO Revenue (Quarterly): 15.92M for April 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2023 | 15.92M |
| January 31, 2023 | 17.92M |
| October 31, 2022 | 26.87M |
| July 31, 2022 | 33.06M |
| April 30, 2022 | 35.95M |
| January 31, 2022 | 41.64M |
| October 31, 2021 | 39.91M |
| July 31, 2021 | 31.54M |
| April 30, 2021 | 17.99M |
| January 31, 2021 | 25.55M |
| October 31, 2020 | 22.28M |
| July 31, 2020 | 19.84M |
| April 30, 2020 | 16.11M |
| Date | Value |
|---|---|
| January 31, 2020 | 12.92M |
| October 31, 2019 | 10.95M |
| July 31, 2019 | 11.61M |
| April 30, 2019 | 9.774M |
| January 31, 2019 | 10.09M |
| October 31, 2018 | 4.344M |
| July 31, 2018 | 1.082M |
| April 30, 2018 | 0.9738M |
| January 31, 2018 | 0.9343M |
| October 31, 2017 | 0.8806M |
| July 31, 2017 | 0.6519M |
| April 30, 2017 | 0.8889M |
| January 31, 2017 | 0.6852M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
4.344M
Minimum
Oct 2018
41.64M
Maximum
Jan 2022
21.28M
Average
17.99M
Median
Apr 2021
Revenue (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 41.49M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.0932M |
| Liminal Biosciences Inc | 0.0833M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -86.43M |
| Total Expenses (Quarterly) | 35.88M |
| EPS Diluted (Quarterly) | -1.939 |
| Gross Profit Margin (Quarterly) | -43.34% |
| Profit Margin (Quarterly) | -543.0% |